vs
Side-by-side financial comparison of Enhabit, Inc. (EHAB) and Westrock Coffee Co (WEST). Click either name above to swap in a different company.
Westrock Coffee Co is the larger business by last-quarter revenue ($339.5M vs $270.4M, roughly 1.3× Enhabit, Inc.). Westrock Coffee Co runs the higher net margin — -6.6% vs -14.3%, a 7.7% gap on every dollar of revenue. On growth, Westrock Coffee Co posted the faster year-over-year revenue change (48.3% vs 4.7%). Westrock Coffee Co produced more free cash flow last quarter ($27.8M vs $3.3M). Over the past eight quarters, Westrock Coffee Co's revenue compounded faster (32.8% CAGR vs 1.5%).
Enhabit, Inc., is a Dallas, Texas-based provider of home health and hospice services. The company operates 255 home health and 110 hospice locations in 34 states with a concentration in Texas, Alabama, Florida, Georgia, Oklahoma and Mississippi. Enhabit is the fourth-largest provider of home health services in the United States and is a leading provider of hospice services. The company was formed in 2022 when Encompass Health spun off its home health and hospice business.
Westrock Coffee Co is a global integrated coffee, tea and functional beverage solutions provider. It sources, roasts, manufactures and distributes coffee products, ready-to-drink beverages and custom formulations for retail, foodservice and commercial clients across North America and other key markets.
EHAB vs WEST — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $270.4M | $339.5M |
| Net Profit | $-38.7M | $-22.6M |
| Gross Margin | — | 11.5% |
| Operating Margin | -12.3% | -2.6% |
| Net Margin | -14.3% | -6.6% |
| Revenue YoY | 4.7% | 48.3% |
| Net Profit YoY | 15.9% | 8.3% |
| EPS (diluted) | $-0.76 | $-0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $270.4M | $339.5M | ||
| Q3 25 | $263.6M | $354.8M | ||
| Q2 25 | $266.1M | $280.9M | ||
| Q1 25 | $259.9M | $213.8M | ||
| Q4 24 | $258.2M | $229.0M | ||
| Q3 24 | $253.6M | $220.9M | ||
| Q2 24 | $260.6M | $208.4M | ||
| Q1 24 | $262.4M | $192.5M |
| Q4 25 | $-38.7M | $-22.6M | ||
| Q3 25 | $11.1M | $-19.1M | ||
| Q2 25 | $5.2M | $-21.6M | ||
| Q1 25 | $17.8M | $-27.2M | ||
| Q4 24 | $-46.0M | $-24.6M | ||
| Q3 24 | $-110.2M | $-14.3M | ||
| Q2 24 | $-200.0K | $-17.8M | ||
| Q1 24 | $200.0K | $-23.7M |
| Q4 25 | — | 11.5% | ||
| Q3 25 | — | 11.7% | ||
| Q2 25 | — | 14.7% | ||
| Q1 25 | — | 13.6% | ||
| Q4 24 | — | 16.6% | ||
| Q3 24 | — | 16.8% | ||
| Q2 24 | — | 19.9% | ||
| Q1 24 | — | 19.4% |
| Q4 25 | -12.3% | -2.6% | ||
| Q3 25 | 6.4% | -2.4% | ||
| Q2 25 | 6.3% | -5.3% | ||
| Q1 25 | 6.1% | -6.1% | ||
| Q4 24 | -16.0% | -4.3% | ||
| Q3 24 | -38.6% | -5.8% | ||
| Q2 24 | 4.3% | -7.9% | ||
| Q1 24 | 4.9% | -5.3% |
| Q4 25 | -14.3% | -6.6% | ||
| Q3 25 | 4.2% | -5.4% | ||
| Q2 25 | 2.0% | -7.7% | ||
| Q1 25 | 6.8% | -12.7% | ||
| Q4 24 | -17.8% | -10.7% | ||
| Q3 24 | -43.5% | -6.5% | ||
| Q2 24 | -0.1% | -8.5% | ||
| Q1 24 | 0.1% | -12.3% |
| Q4 25 | $-0.76 | $-0.22 | ||
| Q3 25 | $0.22 | $-0.20 | ||
| Q2 25 | $0.10 | $-0.23 | ||
| Q1 25 | $0.35 | $-0.29 | ||
| Q4 24 | $-0.92 | $-0.26 | ||
| Q3 24 | $-2.20 | $-0.16 | ||
| Q2 24 | $0.00 | $-0.20 | ||
| Q1 24 | $0.01 | $-0.27 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $43.6M | $49.9M |
| Total DebtLower is stronger | $426.0M | $444.1M |
| Stockholders' EquityBook value | $534.0M | $-1.9M |
| Total Assets | $1.2B | $1.2B |
| Debt / EquityLower = less leverage | 0.80× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $43.6M | $49.9M | ||
| Q3 25 | $56.9M | $34.0M | ||
| Q2 25 | $37.1M | $44.0M | ||
| Q1 25 | $39.5M | $33.1M | ||
| Q4 24 | $28.4M | $26.2M | ||
| Q3 24 | $45.7M | $22.4M | ||
| Q2 24 | $28.5M | $24.3M | ||
| Q1 24 | $36.5M | $12.6M |
| Q4 25 | $426.0M | $444.1M | ||
| Q3 25 | $441.5M | — | ||
| Q2 25 | $456.9M | — | ||
| Q1 25 | $467.3M | — | ||
| Q4 24 | $492.6M | $393.1M | ||
| Q3 24 | $502.9M | — | ||
| Q2 24 | $512.7M | — | ||
| Q1 24 | $526.7M | — |
| Q4 25 | $534.0M | $-1.9M | ||
| Q3 25 | $566.8M | $11.4M | ||
| Q2 25 | $552.4M | $18.2M | ||
| Q1 25 | $543.2M | $71.4M | ||
| Q4 24 | $523.5M | $97.5M | ||
| Q3 24 | $566.1M | $110.3M | ||
| Q2 24 | $674.3M | $81.5M | ||
| Q1 24 | $672.3M | $91.7M |
| Q4 25 | $1.2B | $1.2B | ||
| Q3 25 | $1.2B | $1.2B | ||
| Q2 25 | $1.2B | $1.2B | ||
| Q1 25 | $1.2B | $1.1B | ||
| Q4 24 | $1.2B | $1.1B | ||
| Q3 24 | $1.3B | $1.1B | ||
| Q2 24 | $1.4B | $1.1B | ||
| Q1 24 | $1.4B | $983.3M |
| Q4 25 | 0.80× | — | ||
| Q3 25 | 0.78× | — | ||
| Q2 25 | 0.83× | — | ||
| Q1 25 | 0.86× | — | ||
| Q4 24 | 0.94× | 4.03× | ||
| Q3 24 | 0.89× | — | ||
| Q2 24 | 0.76× | — | ||
| Q1 24 | 0.78× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $4.4M | $36.7M |
| Free Cash FlowOCF − Capex | $3.3M | $27.8M |
| FCF MarginFCF / Revenue | 1.2% | 8.2% |
| Capex IntensityCapex / Revenue | 0.4% | 2.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $65.8M | $-107.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.4M | $36.7M | ||
| Q3 25 | $37.8M | $-26.6M | ||
| Q2 25 | $10.6M | $-7.0M | ||
| Q1 25 | $17.9M | $-22.1M | ||
| Q4 24 | $-4.1M | $2.8M | ||
| Q3 24 | $28.4M | $-332.0K | ||
| Q2 24 | $9.6M | $-23.7M | ||
| Q1 24 | $17.3M | $8.0M |
| Q4 25 | $3.3M | $27.8M | ||
| Q3 25 | $36.2M | $-44.7M | ||
| Q2 25 | $8.7M | $-27.5M | ||
| Q1 25 | $17.6M | $-63.4M | ||
| Q4 24 | $-4.7M | $-15.4M | ||
| Q3 24 | $27.7M | $-36.7M | ||
| Q2 24 | $8.9M | $-59.9M | ||
| Q1 24 | $15.5M | $-60.9M |
| Q4 25 | 1.2% | 8.2% | ||
| Q3 25 | 13.7% | -12.6% | ||
| Q2 25 | 3.3% | -9.8% | ||
| Q1 25 | 6.8% | -29.7% | ||
| Q4 24 | -1.8% | -6.7% | ||
| Q3 24 | 10.9% | -16.6% | ||
| Q2 24 | 3.4% | -28.7% | ||
| Q1 24 | 5.9% | -31.7% |
| Q4 25 | 0.4% | 2.6% | ||
| Q3 25 | 0.6% | 5.1% | ||
| Q2 25 | 0.7% | 7.3% | ||
| Q1 25 | 0.1% | 19.3% | ||
| Q4 24 | 0.2% | 7.9% | ||
| Q3 24 | 0.3% | 16.5% | ||
| Q2 24 | 0.3% | 17.4% | ||
| Q1 24 | 0.7% | 35.8% |
| Q4 25 | — | — | ||
| Q3 25 | 3.41× | — | ||
| Q2 25 | 2.04× | — | ||
| Q1 25 | 1.01× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 86.50× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EHAB
| Third Party Payor Medicare | $111.6M | 41% |
| Third Party Payor Medicare Advantage | $67.5M | 25% |
| Hospice Segment | $63.6M | 24% |
| Third Party Payor Managed Care | $24.9M | 9% |
| Third Party Payor Medicaid | $1.7M | 1% |
WEST
| Coffee And Tea | $202.6M | 60% |
| Flavors Extracts And Ingredients | $69.6M | 21% |
| Sustainable Sourcing And Traceability Segments | $66.9M | 20% |
